Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Chirurgia (Bucur) ; 109(4): 555-8, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25149624

RESUMO

Three cases of primary hydatidosis of the gluteus muscle treated in our department during the last 10 years are described. The first was initially misinterpreted as perineal or sciatic hernia. The diagnosis was set in the operating room. In the second case we included in our differential diagnosis the possibility of parasitic involvement at unusual sites. The diagnosis was confirmed by ultrasonography followed by computed tomography (CT) scans in order to rule out liver and pulmonary involvement. The last patient was initially operated elsewhere but finally came to us to treat his complications. At years following surgery there was no evidence of recurrence in any of the patients, but the last one still suffers from recurrent fasciitis and sciatica.


Assuntos
Equinococose/diagnóstico , Equinococose/parasitologia , Echinococcus granulosus/isolamento & purificação , Músculo Esquelético/parasitologia , Idoso , Albendazol/uso terapêutico , Animais , Anticestoides/uso terapêutico , Nádegas , Equinococose/tratamento farmacológico , Equinococose/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Músculo Esquelético/cirurgia , Resultado do Tratamento
2.
World J Surg ; 24(5): 608-14, 2000 May.
Artigo em Inglês | MEDLINE | ID: mdl-10787085

RESUMO

The biologic significance of bcl-2, bax, and p53 gene expression in patients with non-Hodgkin's gastric lymphoma is unknown. We examined the prognostic value of these genes in 36 patients with gastric lymphoma treated in our clinic between 1990 and 1995. Paraffin-embedded specimens from 36 patients who underwent primary resection of the stomach for gastric lymphoma were analyzed immunohistochemically for p53, bax, and bcl-2 gene expression. Expression of bax was seen in 24 of 36 patients (66.7%), p53 expression was found in 8 of 36 tumors (22.2%), and bcl-2 cytoplasmic staining was detected in 6 of 36 patients (16.7%). We performed a univariate analysis to examine the possible correlation between the expression of these genes and the survival of our patients. Expression of bax protein proved to be a statistically significant prognostic factor (p = 0.049). Protein expression of p53 and bcl-2 did not statistically correlate with survival. In the bcl-2-negative (-) patient group (30 patients), those who were bax-positive had a statistically significant better survival than those who were bax-negative (63.3% vs. 36.7%, p = 0.03). There was also a statistically significant correlation between p53 expression and the grade of the tumor (p = 0.0014). P53 protein expression increased along with the grade. Expression of bax is a significant prognostic factor in patients with gastric lymphoma. Its prognostic value increases significantly when studied in bcl-2-negative patients; but expression of bax failed to be an independent prognostic factor. Expression of bcl-2 and p53 has no prognostic significance. Expression of p53 seems to represent a marker for loss of differentiation.


Assuntos
Linfoma não Hodgkin/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/biossíntese , Proteínas Proto-Oncogênicas/biossíntese , Neoplasias Gástricas/metabolismo , Proteína Supressora de Tumor p53/biossíntese , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Linfoma não Hodgkin/mortalidade , Masculino , Pessoa de Meia-Idade , Prognóstico , Estudos Retrospectivos , Neoplasias Gástricas/mortalidade , Taxa de Sobrevida , Proteína X Associada a bcl-2
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA